FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Manon van Engeland

Research Profile

Physiology

Disorders

Chemicals & Drugs

Geographic Areas

Netherlands

Concepts & Ideas

Co-author Network

Publications

TOP 3
Laura A E Hughes; Mark A Jenkins; Melissa C Southey; Piet A van den Brandt; Manon van Engeland; Michael D Walsh; Matty P Weijenberg; Elizabeth J Williamson; Joanne P Young; R Alexandra Goldbohm; Daniel D Buchanan; Graham G Giles; John L Hopper; Dallas R English
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.
Karin van den Hurk; Joost J van den Oord; Manon van Engeland; Maurice A M van Steensel; Jürgen Veeck; Hanneke E C Niessen; Axel Zur Hausen; Véronique J L Winnepenninckx
Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
Muriel X G Draht; James G Herman; Gerrit A Meijer; Veerle Melotte; Hanneke Niessen; Robert R Riedl; Beatriz Carvalho; Manon van Engeland; Kim M Smits
Promoter CpG island methylation markers in colorectal cancer: the road ahead.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Manon van Engeland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Laura A E Hughes; Mark A Jenkins; Melissa C Southey; Piet A van den Brandt; Manon van Engeland; Michael D Walsh; Matty P Weijenberg; Elizabeth J Williamson; Joanne P Young; R Alexandra Goldbohm; Daniel D Buchanan; Graham G Giles; John L Hopper; Dallas R English
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.
International journal of epidemiology 2012;41(4):1060-72.
2012: Karin van den Hurk; Joost J van den Oord; Manon van Engeland; Maurice A M van Steensel; Jürgen Veeck; Hanneke E C Niessen; Axel Zur Hausen; Véronique J L Winnepenninckx
Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
Biochimica et biophysica acta 2012;1826(1):89-102.
2012: Muriel X G Draht; James G Herman; Gerrit A Meijer; Veerle Melotte; Hanneke Niessen; Robert R Riedl; Beatriz Carvalho; Manon van Engeland; Kim M Smits
Promoter CpG island methylation markers in colorectal cancer: the road ahead.
Epigenomics 2012;4(2):179-94.
2012: Joep P J de Hoon; Manon van Engeland; Jürgen Veeck; Birgit E P J Vriens; Tim G A Calon; Vivianne C G Tjan-Heijnen
Taxane resistance in breast cancer: a closed HER2 circuit?
Biochimica et biophysica acta 2012;1825(2):197-206.
2012: Tjinta Brinkhuizen; Joep P de Hoon; Karin van den Hurk; Manon van Engeland; Ariënne M van Marion; Jürgen Veeck; Véronique J L Winnepenninckx; Maurice A M van Steensel
Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.
PloS one 2012;7(12):e51710.
2011: Laura A E Hughes; Colinda C J M Simons; Piet A van den Brandt; Manon van Engeland; R Alexandra Goldbohm; Matty P Weijenberg
Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort Study.
American journal of epidemiology 2011;174(10):1127-39.
2011: Stefan Wilop; Tim H Brümmendorf; James G Herman; Edgar Jost; Marjolein H F M Lentjes; Manon van Engeland; Thomas B van Gemmeren; Oliver Galm
Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Epigenetics : official journal of the DNA Methylation Society 2011;6(8):1047-52.
2011: Iris J H van Vlodrop; Marcella M L L Baldewijns; Sarah Derks; James G Herman; Hanneke E C Niessen; Wim van Criekinge; Manon van Engeland
Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4225-31.
2011: Brenda W C Bongaerts; Anton F P M de Goeij; Kim A D Wouters; Manon van Engeland; Ralph W H Gottschalk; Frederik J Van Schooten; R Alexandra Goldbohm; Piet A van den Brandt; Matty P Weijenberg
Alcohol consumption, alcohol dehydrogenase 1C (ADH1C) genotype, and risk of colorectal cancer in the Netherlands Cohort Study on diet and cancer.
Alcohol (Fayetteville, N.Y.) 2011;45(3):217-25.
2011: Manon van Engeland; Sarah Derks; Kim M Smits; Gerrit A Meijer; James G Herman
Colorectal cancer epigenetics: complex simplicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(10):1382-91.
2011: Joo-Mi Yi; Mashaal Dhir; Leander Van Neste; Stephanie R Downing; Jana Jeschke; Sabine C Glöckner; Marilia de Freitas Calmon; Craig M Hooker; Juan M Funes; Chris Boshoff; Kim M Smits; Manon van Engeland; Matty P Weijenberg; Christine A Iacobuzio-Donahue; James G Herman; Kornel E Schuebel; Stephen B Baylin; NITA AHUJA
Genomic and epigenomic integration identifies a prognostic signature in colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(6):1535-45.
2011: Laura A E Hughes; Colinda C J M Simons; Piet A van den Brandt; R Alexandra Goldbohm; Anton F P M de Goeij; Adriaan P de Bruïne; Manon van Engeland; Matty P Weijenberg
Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP).
PloS one 2011;6(4):e18571.
2010: Manon van Engeland; James G Herman
Viewing the epigenetics of colorectal cancer through the window of folic acid effects.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1509-12.
2010: Laura A E Hughes; Piet A van den Brandt; R Alexandra Goldbohm; Anton F P M de Goeij; Adriaan P de Bruïne; Manon van Engeland; Matty P Weijenberg
Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort Study.
International journal of epidemiology 2010;39(5):1333-44.
2010: Marcella M Baldewijns; Iris J H van Vlodrop; Peter B Vermeulen; Patricia M M B Soetekouw; Manon van Engeland; Adriaan P de Bruïne
VHL and HIF signalling in renal cell carcinogenesis.
The Journal of pathology 2010;221(2):125-38.
2010: Iris J H van Vlodrop; Marcella M L Baldewijns; Kim M Smits; Leo J Schouten; Leander van Neste; Wim van Criekinge; Hein van Poppel; Evelyne Lerut; Kornel E Schuebel; NITA AHUJA; James G Herman; Adriaan P de Bruïne; Manon van Engeland
Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.
The American journal of pathology 2010;176(2):575-84.
2009: Stefan de Vogel; Kim A D Wouters; Ralph W H Gottschalk; Frederik J Van Schooten; Anton F P M de Goeij; Adriaan P de Bruïne; R Alexandra Goldbohm; Piet A van den Brandt; Matty P Weijenberg; Manon van Engeland
Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):3086-96.
2009: S de Vogel; Matty P Weijenberg; James G Herman; K A D Wouters; A F P M de Goeij; Piet A van den Brandt; A P de Bruïne; Manon van Engeland
MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(7):1216-22.
2009: Laura A E Hughes; Piet A van den Brandt; Adriaan P de Bruïne; Kim A D Wouters; Sarah Hulsmans; Angela Spiertz; R Alexandra Goldbohm; Anton F P M de Goeij; James G Herman; Matty P Weijenberg; Manon van Engeland
Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms.
PloS one 2009;4(11):e7951.
2009: Marcella M Baldewijns; Iris J H van Vlodrop; Kim M Smits; Peter B Vermeulen; Gert G Van den Eynden; Fiona Schot; Tania Roskams; Hein van Poppel; Manon van Engeland; Adriaan P de Bruïne
Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(5):371-82.
2008: Leo J Schouten; Boukje van Dijk; Egbert Oosterwijk; Manon van Engeland; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; R Alexandra Goldbohm; Arnold Kester; Stefan de Vogel; Jack A Schalken; Piet A van den Brandt
Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(12):3543-50.
2008: Stefan de Vogel; Vasundhara Dindore; Manon van Engeland; R Alexandra Goldbohm; Piet A van den Brandt; Matty P Weijenberg
Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer.
The Journal of nutrition 2008;138(12):2372-8.
2008: A H G Cleven; Bradly G Wouters; Bert Schutte; A J G Spiertz; Manon van Engeland; Adriaan P de Bruïne
Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis.
British journal of cancer 2008;99(5):727-33.
2008: Stefan de Vogel; Brenda W C Bongaerts; Kim A D Wouters; Arnold D M Kester; Leo J Schouten; Anton F P M de Goeij; Adriaan P de Bruïne; R Alexandra Goldbohm; Piet A van den Brandt; Manon van Engeland; Matty P Weijenberg
Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.
Carcinogenesis 2008;29(9):1765-73.
2008: Marcella M L Baldewijns; Iris J H van Vlodrop; Leo J Schouten; Patricia M M B Soetekouw; Adriaan P de Bruïne; Manon van Engeland
Genetics and epigenetics of renal cell cancer.
Biochimica et biophysica acta 2008;1785(2):133-55.
2008: Kim M Smits; Leo J Schouten; Boukje van Dijk; Christina A Hulsbergen-van de Kaa; Kim A D Wouters; Egbert Oosterwijk; Manon van Engeland; Piet A van den Brandt
Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):782-7.
2008: Sarah Derks; Cindy Postma; Beatriz Carvalho; Sandra M van den Bosch; Peter Moerkerk; James G Herman; Matty P Weijenberg; Adriaan P de Bruïne; Gerrit A Meijer; Manon van Engeland
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
Carcinogenesis 2008;29(2):434-9.
2007: Kornel E Schuebel; Wei Chen; Leslie Cope; Sabine C Glöckner; Hiromu Suzuki; Joo-Mi Yi; Timothy Chan; Leander Van Neste; Wim van Criekinge; Sandra van den Bosch; Manon van Engeland; Angela H Ting; Kam-Wing Jair; Wayne Yu; Minoru Toyota; Kohzoh Imai; NITA AHUJA; James G Herman; Stephen B Baylin
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
PLoS genetics 2007;3(9):1709-23.
2007: Debby M E I Hellebrekers; Veerle Melotte; Emmanuelle Viré; Elise Langenkamp; Grietje Molema; François Fuks; James G Herman; Wim van Criekinge; Arjan W Griffioen; Manon van Engeland
Identification of epigenetically silenced genes in tumor endothelial cells.
Cancer research 2007;67(9):4138-48.
2007: J M A Pijnenborg; Geeske C Dam de Veen; N Kisters; Bert Delvoux; Manon van Engeland; James G Herman; Patrick G Groothuis
RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):491-7.
2007: Arjen H G Cleven; Manon van Engeland; Bradly G Wouters; Adriaan P de Bruïne
Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(3):229-40.
2007: Debby M E I Hellebrekers; Arjan W Griffioen; Manon van Engeland
Dual targeting of epigenetic therapy in cancer.
Biochimica et biophysica acta 2007;1775(1):76-91.
2006: Stefan de Vogel; Manon van Engeland; Margreet Lüchtenborg; Adriaan P de Bruïne; Guido M J M Roemen; Marjolein H F M Lentjes; R Alexandra Goldbohm; Piet A van den Brandt; Anton F P M de Goeij; Matty P Weijenberg
Dietary folate and APC mutations in sporadic colorectal cancer.
The Journal of nutrition 2006;136(12):3015-21.
2006: Nathalie L G Sieben; Guido M J M Roemen; Jan Oosting; Gert Jan Fleuren; Manon van Engeland; J Prat
Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants.
The Journal of pathology 2006;210(4):405-11.
2006: Debby M E I Hellebrekers; Karolien Castermans; Emmanuelle Viré; Ruud Dings; Nicole T H Hoebers; Kevin H Mayo; mirjam oude egbrink; Grietje Molema; François Fuks; Manon van Engeland; Arjan W Griffioen
Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications.
Cancer research 2006;66(22):10770-7.
2006: Debby M E I Hellebrekers; Kam-Wing Jair; Emmanuelle Viré; Sayaka Eguchi; Nicole T H Hoebers; Mario F Fraga; Manel Esteller; François Fuks; Stephen B Baylin; Manon van Engeland; Arjan W Griffioen
Angiostatic activity of DNA methyltransferase inhibitors.
Molecular cancer therapeutics 2006;5(2):467-75.
2006: J M A Pijnenborg; Leonie van de Broek; Geeske C Dam de Veen; Guido M J M Roemen; Jelte de Haan; Manon van Engeland; Jan Willem Voncken; Patrick G Groothuis
TP53 overexpression in recurrent endometrial carcinoma.
Gynecologic oncology 2006;100(2):397-404.
2006: Sarah Derks; Cindy Postma; Peter Moerkerk; Sandra M van den Bosch; Beatriz Carvalho; Mario A J A Hermsen; Walter Giaretti; James G Herman; Matty P Weijenberg; Adriaan P de Bruïne; Gerrit A Meijer; Manon van Engeland
Promoter methylation precedes chromosomal alterations in colorectal cancer development.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2006;28(5-6):247-57.
2005: Nathalie L G Sieben; Jan Oosting; Adrienne M Flanagan; Jaime Prat; Guido M J M Roemen; Sandra M Kolkman-Uljee; Ronald van Eijk; Cees J Cornelisse; Gert Jan Fleuren; Manon van Engeland
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7257-64.
2005: Johann C Brandes; Manon van Engeland; Kim A D Wouters; Matty P Weijenberg; James G Herman
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.
Carcinogenesis 2005;26(6):1152-6.
2005: Mirian Brink; Matty P Weijenberg; Anton F P M de Goeij; Guido M J M Roemen; Marjolein H F M Lentjes; Adriaan P de Bruïne; Manon van Engeland; R Alexandra Goldbohm; Piet A van den Brandt
Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
International journal of cancer. Journal international du cancer 2005;114(5):824-30.
2004: J M A Pijnenborg; N Kisters; Manon van Engeland; G A J Dunselman; Jelte de Haan; Anton F P M de Goeij; Patrick G Groothuis
APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(5):947-56.
2004: J M A Pijnenborg; Geeske C Dam de Veen; Jelte de Haan; Manon van Engeland; Patrick G Groothuis
Defective mismatch repair and the development of recurrent endometrial carcinoma.
Gynecologic oncology 2004;94(2):550-9.
2004: Margreet Lüchtenborg; Matty P Weijenberg; Guido M J M Roemen; Adriaan P de Bruïne; Piet A van den Brandt; Marjolein H F M Lentjes; Mirian Brink; Manon van Engeland; R Alexandra Goldbohm; Anton F P M de Goeij
APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study.
Carcinogenesis 2004;25(7):1219-26.
2004: Hiromu Suzuki; DAVID WATKINS; Kam-Wing Jair; Kornel E Schuebel; Sanford D Markowitz; Wei Dong Chen; Theresa P Pretlow; Bin Yang; Yoshimitsu Akiyama; Manon van Engeland; Minoru Toyota; Takashi Tokino; Yuji Hinoda; Kohzoh Imai; James G Herman; Stephen B Baylin
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
Nature genetics 2004;36(4):417-22.
2004: Sarah Derks; Marjolein H F M Lentjes; Debby M E I Hellebrekers; Adriaan P de Bruïne; James G Herman; Manon van Engeland
Methylation-specific PCR unraveled.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2004;26(5-6):291-9.
2003: Yoshimitsu Akiyama; Neil Watkins; Hiromu Suzuki; Kam-Wing Jair; Manon van Engeland; Manel Esteller; Hidekazu Sakai; Chun-Yan Ren; Yasuhito Yuasa; James G Herman; Stephen B Baylin
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.
Molecular and cellular biology 2003;23(23):8429-39.
2003: Manon van Engeland; Matty P Weijenberg; Guido M J M Roemen; Mirian Brink; Adriaan P de Bruïne; R Alexandra Goldbohm; Piet A van den Brandt; Stephen B Baylin; Anton F P M de Goeij; James G Herman
Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.
Cancer research 2003;63(12):3133-7.
2002: Hiromu Suzuki; Edward Gabrielson; Wei Chen; Ramaswamy Anbazhagan; Manon van Engeland; Matty P Weijenberg; James G Herman; Stephen B Baylin
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.
Nature genetics 2002;31(2):141-9.
2002: Manon van Engeland; Guido M J M Roemen; Mirian Brink; Marco M M Pachen; Matty P Weijenberg; Adriaan P de Bruïne; Jan-Willem Arends; Piet A van den Brandt; Anton F P M de Goeij; James G Herman
K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
Oncogene 2002;21(23):3792-5.
1998: Manon van Engeland; LJ Nieland; Frans C S Ramaekers; Bert Schutte; Chris P M Reutelingsperger
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.
Cytometry 1998;31(1):1-9.
1997: Bert Schutte; LJ Nieland; Manon van Engeland; Mieke Henfling; L Meijer; Frans C S Ramaekers
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Experimental cell research 1997;236(1):4-15.
1997: Manon van Engeland; Helma J H Kuijpers; Frans C S Ramaekers; Chris P M Reutelingsperger; Bert Schutte
Plasma membrane alterations and cytoskeletal changes in apoptosis.
Experimental cell research 1997;235(2):421-30.
1996: Barbie M Machiels; Mieke Henfling; Bert Schutte; Manon van Engeland; Jos L V Broers; Frans C S Ramaekers
Subcellular localization of proteasomes in apoptotic lung tumor cells and persistence as compared to intermediate filaments.
European journal of cell biology 1996;70(3):250-9.
1996: Manon van Engeland; Frans C S Ramaekers; Bert Schutte; Chris P M Reutelingsperger
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.
Cytometry 1996;24(2):131-9.